Proinflammatory cytokines in heart disease
CA Dinarello, BJ Pomerantz - Blood purification, 2001 - karger.com
Proinflammatory cytokines affect nearly all tissues and organ systems, and the vasculature is
no exception. Although a considerable amount of research has focused on the role of the …
no exception. Although a considerable amount of research has focused on the role of the …
Role of cytokines in myocardial ischemia and reperfusion
HS Sharma, DK Das - Mediators of inflammation, 1997 - Wiley Online Library
Mediators of myocardial inflammation, predominantly cytokines, have for many years been
implicated in the healing processes after infarction. In recent years, however, more attention …
implicated in the healing processes after infarction. In recent years, however, more attention …
Status of cytokines in ischemia reperfusion induced heart injury
M Zhang, L Chen - Cardiovascular & Haematological Disorders …, 2008 - ingentaconnect.com
Extensive investigations have implicated cytokines such as tumour necrosis factor (TNF)-α
and interleukin (IL)-1, and IL-6 as contributing to the pathology of ischemia-reperfusion (I/R) …
and interleukin (IL)-1, and IL-6 as contributing to the pathology of ischemia-reperfusion (I/R) …
Effect of inflammatory mediators on cardiovascular function
U Mueller-Werdan, R Prondzinsky… - Current opinion in …, 2016 - journals.lww.com
Effect of inflammatory mediators on cardiovascular function : Current Opinion in Critical Care
Effect of inflammatory mediators on cardiovascular function : Current Opinion in Critical Care …
Effect of inflammatory mediators on cardiovascular function : Current Opinion in Critical Care …
[HTML][HTML] Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart
BACKGROUND: Several investigations have implicated cytokines such as tumour necrosis
factor-alpha (TNF-α), interleukin (IL)-1, IL-6, IL-8 and transforming growth factor-beta in the …
factor-alpha (TNF-α), interleukin (IL)-1, IL-6, IL-8 and transforming growth factor-beta in the …
Inflammation in coronary artery disease and acute myocardial infarction-is the stage set for novel therapies?
R Klingenberg, TF Luscher - Current pharmaceutical design, 2012 - ingentaconnect.com
Acute myocardial infarction (AMI) constitutes the major cause of death in most nations and
death rates and morbidity remain substantial in the years thereafter. Inflammation is a …
death rates and morbidity remain substantial in the years thereafter. Inflammation is a …
A review of interleukin-1 in heart disease: where do we stand today?
Y Szekely, Y Arbel - Cardiology and therapy, 2018 - Springer
Cardiovascular diseases are the leading cause of death worldwide. Research in the last two
decades has emphasized the inflammatory process as a key component in the …
decades has emphasized the inflammatory process as a key component in the …
Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy
L Airaghi, M Lettino, MG Manfredi, JM Lipton… - American Heart …, 1995 - Elsevier
We tested the idea that cytokine antagonists are released during acute myocardial ischemia
to counteract proinflammatory effects of cytokines. We investigated changes in plasma …
to counteract proinflammatory effects of cytokines. We investigated changes in plasma …
Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease
MN Sack - Pharmacology & therapeutics, 2002 - Elsevier
The functional role of tumor necrosis factor (TNF)-α in the heart has been extensively studied
over the last 15 years. Collectively, these studies have demonstrated that TNF-α has both …
over the last 15 years. Collectively, these studies have demonstrated that TNF-α has both …
The utility of anti-inflammatory agents in cardiovascular disease: a novel perspective on the treatment of atherosclerosis
SJ Kottoor, RR Arora - Journal of cardiovascular …, 2018 - journals.sagepub.com
Approximately 40% of heart attack survivors remain at increased risk of recurrent
cardiovascular events, despite the current treatment options showing that atherothrombosis …
cardiovascular events, despite the current treatment options showing that atherothrombosis …